English
|
Spanish
Login
Register
For the latest
e
cancer COVID-19 resources, click on this link
Home
News
Journal
Video
e
learning
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
Conferences
Sign up for latest coverage
Submit your event
Conferences
e
cancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Past
Upcoming
Category
All
Disease Areas
Patient Care
Policy
Prevention & screening
Treatments
Sub-category
All
Region
All
Asia
Middle East and North Africa
Europe
North America
Central America and the Caribbean
South America
Africa
Australia and Oceania
Country
All
Year
All
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Keyword
EHA 2019
13 - 16 Jun 2019
RAI Amsterdam, Amsterdam, Netherlands
Videos
News
Chemotherapy-free strategies in treating leukaemia
Prof Robin Foa - University of Rome, Rome, Italy
20 Jun 2019
Dasatinib-blinatumomab combination for the front-line treatment of adult Ph-posi...
Prof Robin Foa - University of Rome, Rome, Italy
20 Jun 2019
Dose escalation of REGN1979 in patients with relapsed and refractory B-NHL
Prof Max Topp - University of Würzburg, Würzburg, Germany
20 Jun 2019
CD-19 mutation frequency after blinatumomab treatment is lower than after CAR T-...
Dr Michaela Kotrova - Universitätsklinikum Schleswig-Holstein, Kiel, Germany
20 Jun 2019
ADMIRAL trial results: Gilteritinib versus salvage chemotherapy in patients with...
Prof Alexander Perl - University of Pennsylvania, Philadelphia, USA
20 Jun 2019
Multiple myeloma science from EHA 2019
Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France
20 Jun 2019
CAR T-cell therapy for treating acute leukaemia
Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France
20 Jun 2019
Selinexor plus cytarabine and idarubicin in patients with relapsed/refractory ac...
Prof Walter Fiedler - University of Hamburg, Hamburg, Germany
20 Jun 2019
ECHELON-1 study 3 year update: Frontline brentuximab vedotin with chemotherapy f...
Dr Andrea Gallamini - Centre Antoine Lacassagne, Nice, France
20 Jun 2019
Controlling CRS-related coagulopathy improves the safety of CAR T-cell therapy f...
Dr Heng Mei - Huazhong University of Science and Technology, Wuhan, China
20 Jun 2019
ICARIA results: Treating RRMM patients with isatuximab, pomalidomide and low-dos...
Prof Paul Richardson - Dana-Farber Cancer Institute, Boston, USA
20 Jun 2019
HORIZON update: Using melflufen to treat RRMM patients refractory to daratumumab...
Prof Paul Richardson - Dana-Farber Cancer Institute, Boston, USA
20 Jun 2019
PET after 2 cycles of ABVD in patients with early-stage favourable Hodgkin lymph...
Michael Fuchs - University Hospital of Cologne, Cologne, Germany
20 Jun 2019
Safety and efficacy of escalating doses of Hu5F9-G4 with rituximab in patients w...
Dr Mark Roschewski - National Cancer Institute, Bethesda, USA
20 Jun 2019
Combination of pegcrisantaspase and venetoclax in acute myeloid leukaemia
Dr Ashkan Emadi - University of Maryland Medical Centre, Maryland, USA
20 Jun 2019
CLL12 trial: Ibrutinib in previously untreated, asymptomatic early-stage CLL
Dr Othman Al-Sawaf - University of Cologne, Cologne, Germany
20 Jun 2019
Chemoimmunotherapy or BTK inhibition for patients with CLL
Dr Othman Al-Sawaf - University of Cologne, Cologne, Germany
20 Jun 2019
MOR208 plus lenalidomide in r-r diffuse large B-cell lymphoma
Dr Johannes Düll - University of Würzburg, Würzburg, Germany
20 Jun 2019
Blinatumomab for relapsed/refractory Burkitt's lymphoma
Dr Johannes Düll - University of Würzburg, Würzburg, Germany
20 Jun 2019
Using bioinformatics and genomics to treat AML
Prof Torsten Haferlach - MLL Münchner Leukämielabor GmbH, Munich, Germany
20 Jun 2019
The changing landscape of AML
Prof Torsten Haferlach - MLL Münchner Leukämielabor GmbH, Munich, Germany
20 Jun 2019
CLL14: A chemotherapy-free regimen of venetoclax plus obinutuzumab for CLL
Dr Othman Al-Sawaf - Univesity of Cologne, Cologne, Germany
20 Jun 2019
RESONATE-2: Five-year follow up of CLL patients receiving ibrutinib as first-lin...
Dr Alessandra Tedeschi - Azienda Ospedaliera Niguarda Cà Granda Milano, Milano, ...
19 Jun 2019
CD33 T cell recruiting antibody constructs for treatment of relapsed refractory ...
Prof Marion Subklewe - LMU Hospital Munich, Munich, Germany
19 Jun 2019
Targeted treatment of AML using T cell recruiting antibody constructs
Prof Marion Subklewe - LMU Hospital Munich, Munich, Germany
19 Jun 2019
Use of maintenance therapy following ASCT and real world treatment patterns in m...
Dr Evangelos Terpos, Prof Michele Cavo, Dr Eloísa Riva, Dr Fredrik Schjesvold
15 Jun 2019
Myeloma highlights from EHA 2019
Prof Maria-Victoria Mateos - University of Salamanca, Salamanca, Spain
15 Jun 2019
Comment: Pregnancy outcomes in patients with chronic myeloid leukaemia
Prof Anton Hagenbeek - University of Amsterdam, Amsterdam, The Netherlands
15 Jun 2019
Comment: Fixed-duration venetoclax plus obinutuzumab in patients with CLL and co...
Prof Anton Hagenbeek - University of Amsterdam, Amsterdam, The Netherlands
15 Jun 2019
AlloHCT conditioning intensity in AML in complete remission with residual diseas...
Dr Christopher Hourigan - National Heart, Lung, and Blood Institute, Bethesda, U...
15 Jun 2019
ASCEND: Acalabrutinib versus rituximab with idelalisib or bendamustine in relaps...
Prof Paolo Ghia - Vita-Salute San Raffaele University, Milan, Italy
15 Jun 2019
Inhibition of NADK strongly inhibits T-ALL cells from growing
Dr Etienne De Braekeleer - Wellcome Sanger Institute, Cambridge, UK
15 Jun 2019
Novel immunotherapy 5F9 plus rituximab well tolerated with rapid and durable res...
Dr Mark Roschewski - National Cancer Institute, Bethesda, USA
15 Jun 2019
Venetoclax with bortezomib and dexamethasone shows good response but higher risk...
Dr Shaji Kumar - Mayo Clinic, Rochester, USA
15 Jun 2019
Acalabrutinib monotherapy shows significant benefit in relapsed or refractory ch...
Dr Paolo Ghia - Vita-Salute San Raffaele University, Milan, Italy
15 Jun 2019
Imetelstat provides durable transfusion independence in heavily transfused non-d...
Dr Pierre Fenaux - Hôpital St Louis and Paris University, Paris, France
14 Jun 2019
D-VTd in induction prior to and consolidation after ASCT improves PFS and depth ...
Prof Philippe Moreau - Chu Nantes, Nantes, France
14 Jun 2019
Venetoclax plus obinutuzumab improves PFS and MRD-negativity in patients with pr...
Dr Kirsten Fischer - Uniklinik Köln, Cologne, Germany
14 Jun 2019
Most pregnancies in CML patients resulted in normal childbirth: Analysis of 305 ...
Dr Ekaterina Chelysheva - National Research Center for Hematology, Moscow, Russ...
14 Jun 2019
Intervention for AML patients with MRD can result in improved survival
Dr Christopher Hourigan - Laboratory of Myeloid Malignancies, National Heart, Lu...
14 Jun 2019
More from
e
cancer